Kyverna Therapeutics(KYTX.US)

Last Updated 19:00:00 ET
longbridge loading

Wells Fargo Remains a Buy on Kyverna Therapeutics, Inc. (KYTX)

Tip Ranks·
US
KYTX
+3.50%
US
FBT
+0.71%
US
BBH
+0.68%
Tip Ranks·
US
KYTX
+3.50%
US
FBT
+0.71%
US
BBH
+0.68%

Kyverna Therapeutics | 10-Q: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
KYTX
+3.50%
Earnings Watch·
US
KYTX
+3.50%

Kyverna Therapeutics | 8-K: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
KYTX
+3.50%
Earnings Watch·
US
KYTX
+3.50%

Kyverna Therapeutics (KYTX) to Release Earnings on Tuesday

Market Beat·
US
KYTX
+3.50%
US
BIB
+1.33%
US
IBB
+0.84%
Market Beat·
US
KYTX
+3.50%
US
BIB
+1.33%
US
IBB
+0.84%

Kyverna taps CCO as CAR-T autoimmune first comes into view

Fiercepharma·
US
KYTX
+3.50%
US
IBBQ
+0.89%
US
FBT
+0.71%
Fiercepharma·
US
KYTX
+3.50%
US
IBBQ
+0.89%
US
FBT
+0.71%
© 2026 Longbridge｜Disclaimer